11月 2025
- 首頁
- ABIOMED
11月 2025ABIOMED的市場佔有率分析
Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices.
ABIOMED(包含公司地區)
查看更多網站流量與參與度資訊- abiomed.com
ABIOMED截至 11月 2025 的總收入為 > 1B
ABIOMED 熱門網域產生的總收入
ABIOMED 熱門網域 3 年內的總收入
ABIOMED 熱門網域的總收入
ABIOMED的熱門網域總造訪量
了解ABIOMED市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
ABIOMED的熱門網域平均造訪時長
分析ABIOMED參與度指標。
過去 3 個月平均造訪時長
子公司細目
ABIOMED的熱門網域平均頁面瀏覽量
了解ABIOMED如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自ABIOMED
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Norton Healthcare Provider partners with Abiomed, Inc..After discussion with its surgical, VAD, and Congenital Heart Failure teams, Norton Healthcare Provider worked with Abiomed to acquire the relatively new Impella RP Flex that was placed percutaneously to support the right ventricle.
7月 21, 2025閱讀更多
新聞Jnjmedtech acquired Abiomed, Inc. for $16.6B on Dec 31st '22.J&J acquired the heart pump maker Abiomed in a deal worth $16.6 billion at the end of 2022.
1月 22, 2025閱讀更多
新聞Johnson & Johnson acquired Abiomed, Inc. for $16B on Jan 1st '22.With the addition of V-Wave, J&J continues to build its cardiovascular device portfolio, after spending $16.6 billion to acquire Abiomed in 2022 and $13.1 billion to purchase Shockwave Medical earlier this year.
8月 20, 2024閱讀更多
查看所有ABIOMED信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。